FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1551517943> ?p ?o ?g. }

• W1551517943 endingPage "4900" @default.
• W1551517943 startingPage "4888" @default.
• W1551517943 abstract "// Xiaolu Zhang 1, * , Bingnan Li 1, * , Nick de Jonge 1 , Magnus Björkholm 1 , Dawei Xu 1 1 Department of Medicine, Division of Hematology and Center for Molecular Medicine, Karolinska Institutet and Karolinska University Hospital Solna, Stockholm, Sweden * These authors have contributed equally to this work Correspondence to: Dawei Xu, e-mail: Dawei.Xu@ki.se Keywords: AML, Apoptosis, DNMT inhibitors, Telomerase, Telomere, TERT Received: November 16, 2014      Accepted: December 14, 2014      Published: January 06, 2015 ABSTRACT DNA methyltransferase inhibitors (DNMTIs) such as 5-azacytidine (5-AZA) have been used for treatment of acute myeloid leukemia (AML) and other malignancies. Although inhibiting global/gene-specific DNA methylation is widely accepted as a key mechanism behind DNMTI anti-tumor activity, other mechanisms are likely involved in DNMTI's action. Because telomerase reverse transcriptase (TERT) plays key roles in cancer through telomere elongation and telomere lengthening-independent activities, and TERT has been shown to confer chemo- or radio-resistance to cancer cells, we determine whether DNMTIs affect telomere function and whether TERT/telomerase interferes with their anti-cancer efficacy. We showed that 5-AZA induced DNA damage and telomere dysfunction in AML cell lines by demonstrating the presence of 53-BP1 foci and the co-localization of 53-BP1 foci with telomere signals, respectively. Telomere dysfunction was coupled with diminished TERT expression, shorter telomere and apoptosis in 5-AZA-treated cells. However, 5-AZA treatment did not lead to changes in the methylation status of subtelomere regions. Down-regulation of TERT expression similarly occurred in primary leukemic cells derived from AML patients exposed to 5-AZA. TERT over-expression significantly attenuated 5-AZA-mediated DNA damage, telomere dysfunction and apoptosis of AML cells. Collectively, 5-AZA mediates the down-regulation of TERT expression, and induces telomere dysfunction, which consequently exerts an anti-tumor activity." @default.
• W1551517943 created "2016-06-24" @default.
• W1551517943 creator A5046644939 @default.
• W1551517943 creator A5057660178 @default.
• W1551517943 creator A5062141650 @default.
• W1551517943 creator A5071951805 @default.
• W1551517943 creator A5076576350 @default.
• W1551517943 date "2015-02-17" @default.
• W1551517943 modified "2023-10-10" @default.
• W1551517943 title "The DNA methylation inhibitor induces telomere dysfunction and apoptosis of leukemia cells that is attenuated by telomerase over-expression" @default.
• W1551517943 cites W1878249864 @default.
• W1551517943 cites W1910707300 @default.
• W1551517943 cites W1948390230 @default.
• W1551517943 cites W1964767882 @default.
• W1551517943 cites W1966346464 @default.
• W1551517943 cites W1971846400 @default.
• W1551517943 cites W1991858306 @default.
• W1551517943 cites W1994625921 @default.
• W1551517943 cites W1996919750 @default.
• W1551517943 cites W1997638561 @default.
• W1551517943 cites W1998111191 @default.
• W1551517943 cites W1998661629 @default.
• W1551517943 cites W2002840337 @default.
• W1551517943 cites W2004023747 @default.
• W1551517943 cites W2007999442 @default.
• W1551517943 cites W2009448733 @default.
• W1551517943 cites W2014324433 @default.
• W1551517943 cites W2015005515 @default.
• W1551517943 cites W2021836517 @default.
• W1551517943 cites W2027070119 @default.
• W1551517943 cites W2033861401 @default.
• W1551517943 cites W2038424386 @default.
• W1551517943 cites W2039393926 @default.
• W1551517943 cites W2040393829 @default.
• W1551517943 cites W2041278400 @default.
• W1551517943 cites W2041690843 @default.
• W1551517943 cites W2042897772 @default.
• W1551517943 cites W2046466087 @default.
• W1551517943 cites W2051815880 @default.
• W1551517943 cites W2055902044 @default.
• W1551517943 cites W2064893357 @default.
• W1551517943 cites W2070338308 @default.
• W1551517943 cites W2074167295 @default.
• W1551517943 cites W2074991976 @default.
• W1551517943 cites W2075388602 @default.
• W1551517943 cites W2078805336 @default.
• W1551517943 cites W2090521798 @default.
• W1551517943 cites W2091609286 @default.
• W1551517943 cites W2093507272 @default.
• W1551517943 cites W2098744299 @default.
• W1551517943 cites W2100941174 @default.
• W1551517943 cites W2108586948 @default.
• W1551517943 cites W2120086108 @default.
• W1551517943 cites W2137153793 @default.
• W1551517943 cites W2141470331 @default.
• W1551517943 cites W2149045518 @default.
• W1551517943 cites W2149816812 @default.
• W1551517943 cites W2152398648 @default.
• W1551517943 cites W2153760279 @default.
• W1551517943 cites W2162043650 @default.
• W1551517943 cites W2171968985 @default.
• W1551517943 cites W321316306 @default.
• W1551517943 cites W4250670238 @default.
• W1551517943 doi "https://doi.org/10.18632/oncotarget.2917" @default.
• W1551517943 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4467122" @default.
• W1551517943 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25682873" @default.
• W1551517943 hasPublicationYear "2015" @default.
• W1551517943 type Work @default.
• W1551517943 sameAs 1551517943 @default.
• W1551517943 citedByCount "30" @default.
• W1551517943 countsByYear W15515179432015 @default.
• W1551517943 countsByYear W15515179432016 @default.
• W1551517943 countsByYear W15515179432017 @default.
• W1551517943 countsByYear W15515179432018 @default.
• W1551517943 countsByYear W15515179432019 @default.
• W1551517943 countsByYear W15515179432020 @default.
• W1551517943 countsByYear W15515179432021 @default.
• W1551517943 countsByYear W15515179432022 @default.
• W1551517943 countsByYear W15515179432023 @default.
• W1551517943 crossrefType "journal-article" @default.
• W1551517943 hasAuthorship W1551517943A5046644939 @default.
• W1551517943 hasAuthorship W1551517943A5057660178 @default.
• W1551517943 hasAuthorship W1551517943A5062141650 @default.
• W1551517943 hasAuthorship W1551517943A5071951805 @default.
• W1551517943 hasAuthorship W1551517943A5076576350 @default.
• W1551517943 hasBestOaLocation W15515179431 @default.
• W1551517943 hasConcept C104317684 @default.
• W1551517943 hasConcept C121608353 @default.
• W1551517943 hasConcept C125593758 @default.
• W1551517943 hasConcept C150194340 @default.
• W1551517943 hasConcept C153911025 @default.
• W1551517943 hasConcept C177336024 @default.
• W1551517943 hasConcept C190283241 @default.
• W1551517943 hasConcept C190727270 @default.
• W1551517943 hasConcept C2778729363 @default.
• W1551517943 hasConcept C502942594 @default.
• W1551517943 hasConcept C54355233 @default.
• W1551517943 hasConcept C552990157 @default.

• next